Company: TVRD
Filing Date: 2025-02-14
Form Type: 424B3
Source: 0001104659-25-014310
Chunk: 656

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: 424B3
Chunk 656
---
 officers are initially established through arm’s-length negotiations at the time of the executive officer’s hiring, taking into account such executive officer’s qualifications, experience, the scope of such executive officer’s responsibilities and competitive market compensation paid by other companies for similar positions within the industry and geography. Base salaries are reviewed periodically, typically in connection with Tvardi’s annual review process, and adjusted from time to time to realign salaries with market levels after taking into account individual responsibilities, performance, experience and adjustments to reflect cost of living increases. In making decisions regarding salary increases, Tvardi may also draw upon the experience of members of its board of directors with executives at other companies. The 2024 annual base salaries for its named executive officers are set forth in the table below:

| Name                   | ​ | ​ | BaseSalary ($) |   |         |   | ​ |
| Imran Alibhai, Ph.D.   | ​ | ​ | ​              | ​ | 551,050 | ​ | ​ |
| John Kauh, M.D.        | ​ | ​ | ​              | ​ | 412,000 | ​ | ​ |
| Dan Conn, J.D., M.B.A. | ​ | ​ | ​              | ​ | 381,100 | ​ | ​ |

Annual Performance Bonus Opportunity For 2024, Tvardi named executive officers were eligible to receive discretionary annual performance bonuses based on individual performance, company performance or as otherwise determined appropriate, as determined by its board of directors. For 2023 and 2024, each of Drs. Alibhai and Kauh and Mr. Conn were eligible to receive a target bonus equal to 50%, 30% and 30% of his base salary, respectively. In January 2024, the Tvardi board of directors approved and paid annual performance bonuses for Drs. Alibhai and Kauh and Mr. Conn in the amounts of $267,500, $110,466 and $111,000, respectively. In January 2025, the Tvardi board of directors approved and paid annual performance bonuses for Drs. Alibhai and Kauh in the amounts of $275,525 and $123,600, respectively. In recognition of Mr. Conn’s additional efforts in 2024 in connection with the Merger and the Convertible Note financing completed or entered into in 2024, the Tvardi board of directors approved and paid an annual performance bonus for Mr. Conn of